Freeport-McMoRan 10-Qquarter ended 2026-06-30

Executive Summary

Freeport-McMoRan’s Q2 2026 showed higher common-stockholder earnings despite weaker underlying operations: higher metal prices and a smaller noncontrolling-interest share offset sharply reduced Grasberg volumes. Revenue fell 7.3%, operating income fell 18%, and earnings attributable to common stockholders rose 27%; H1 also benefited from a substantial insurance settlement and lower taxes. The investment thesis centers on safely restoring Indonesia production while expanding lower-capital-intensity copper leaching in the U.S. Cash generation supports investment and shareholder distributions, but recovery execution, commodity prices and Indonesian regulatory exposure remain the decisive risks.

Key Financial Highlights

• Earnings quality: H1 operating income included a $699M insurance-settlement gain; excluding it, operating income was $3.44B vs GAAP $4.14B. The effective tax rate declined to 30% from 37%, while reduced noncontrolling-interest income further boosted attributable earnings.
• Cash conversion: H1 OCF exceeded total net income but included $700M of insurance proceeds and absorbed $457M of working-capital and other uses; the cash improvement was not solely recurring operating performance.
• Capital returns: H1 repurchases of $203M and dividends of $434M accompanied stock-based compensation of $103M. Shares outstanding nevertheless increased from 1.627B to 1.630B, so repurchases did not shrink the share count net of issuance.
• Financing: Debt carrying value was $9.39B against $4.08B of cash and equivalents; current debt rose to $1.22B from $466M. A replacement $3.0B revolver extends committed funding to 2031, while H1 interest costs included $67M of nonrecurring withholding-tax adjustments.

Business Developments

• Grasberg recovery: Remediation of Production Blocks 2 and 3 was completed, and the phased ramp-up achieved planned Q2 operating rates. Management expects ≈65% capacity in H2 2026, 80% by mid-2027 and near-full capacity by end-2027.
• Revenue mix: Q2 concentrate revenue fell to $976M from $2.02B and gold to $640M from $1.83B, while cathode and rod/refined copper increased. PTFI’s integrated downstream facilities shift sales toward refined products, although smelter inventory can defer sales relative to production.
• Growth allocation: Leaching initiatives target faster copper additions, while Bagdad and El Abra remain larger, conditional options with estimated capital requirements of ≈$4.5B and ≈$7.5B. Management could decide on Bagdad in H2 2026.
• Indonesian tenure: A memorandum of understanding contemplates operating rights beyond 2041, with FCX’s interest declining from 48.76% to ≈37% from 2042; approval and definitive agreements remain outstanding.

Risk Assessment

• Recovery execution: Indonesia’s Q2 copper sales fell to 153M pounds from 443M; further disruption would delay revenue recovery and prolong idle-facility and restoration costs, forecast at ≈$1.2B for FY 2026.
• Commodity exposure: Strong realized prices supported earnings despite volume losses, while 194M pounds of provisionally priced copper sales create additional settlement sensitivity.
• Indonesian regulatory exposure: Longer operating tenure depends on government approval, with the proposed ownership reduction lowering FCX’s future economic participation.
• Compliance investigation: The SEC declined enforcement on 3/17/2026, but the PT Smelting investigation remains unresolved and could produce penalties under other laws or jurisdictions.
• Project and cost exposure: Large expansion options face permitting, construction and market risks; environmental and asset-retirement obligations total $5.94B.

This 10-Q lists only the risk factors that changed since the annual report. Full list: the company's 10-Ks on SEC.

Strategic Outlook and Investor Actionables

Management is betting on Grasberg normalization and incremental leach recovery to translate copper-price strength into sustained production and cash generation. The opportunity is greater output from existing assets; the threat is that disruption costs and investment needs consume the benefit.

• Grasberg: Track capacity against management’s recovery milestones and Indonesia sales from Q2’s 153M copper pounds; rising sales and declining restoration costs validate recovery, while renewed delays undermine it.
• Leaching: Q2 incremental production was 47M pounds against management’s 300M-pound annual run-rate target by year-end 2026; accelerating output validates the initiative, while stalled production weakens it.
• Cash funding: Test management’s FY guidance of $8.3B OCF and $4.3B capital expenditures; delivery would support investment and distributions, while shortfalls accompanied by rising borrowing would narrow flexibility.